Is low hsCRP a good thing?

Low hsCRP levels (below 1.0 mg/L) are generally excellent, indicating minimal inflammation and lower risk of cardiovascular disease and other chronic conditions. However, extremely low levels don't require concern unless accompanied by symptoms of immune dysfunction.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

What is hsCRP and Why Does It Matter?

High-sensitivity C-reactive protein (hsCRP) is a blood biomarker that measures inflammation in your body. Unlike standard CRP tests used to detect acute infections or injuries, hsCRP can detect much lower levels of inflammation, making it particularly valuable for assessing cardiovascular disease risk and overall health status.

Your liver produces C-reactive protein in response to inflammation anywhere in your body. While acute inflammation helps fight infections and heal injuries, chronic low-grade inflammation contributes to numerous health problems, including heart disease, diabetes, and certain cancers. This is why monitoring your hsCRP levels provides crucial insights into your long-term health trajectory.

Understanding hsCRP Level Ranges

Medical professionals categorize hsCRP levels into distinct risk categories for cardiovascular disease. Understanding where your levels fall helps you and your healthcare provider make informed decisions about prevention and treatment strategies.

Low Risk: Less Than 1.0 mg/L

If your hsCRP is below 1.0 mg/L, you're in the low-risk category for cardiovascular disease. This indicates minimal systemic inflammation and suggests your body isn't dealing with significant inflammatory processes. People in this range typically have healthier lifestyles and lower rates of chronic disease.

Average Risk: 1.0 to 3.0 mg/L

Levels between 1.0 and 3.0 mg/L indicate average cardiovascular risk. While not immediately concerning, this range suggests some degree of inflammation that could benefit from lifestyle modifications to prevent progression to higher risk categories.

High Risk: Above 3.0 mg/L

hsCRP levels above 3.0 mg/L place you in the high-risk category for cardiovascular events. This elevation warrants further investigation to identify and address underlying causes of inflammation. Values above 10 mg/L typically indicate acute inflammation from infection or injury rather than chronic low-grade inflammation.

The Benefits of Low hsCRP Levels

Having low hsCRP levels offers numerous health advantages beyond just cardiovascular protection. Research consistently shows that people with lower inflammatory markers enjoy better overall health outcomes and increased longevity.

Cardiovascular Protection

Low hsCRP levels strongly correlate with reduced risk of heart attacks, strokes, and other cardiovascular events. Studies show that individuals with hsCRP below 1.0 mg/L have approximately half the cardiovascular risk compared to those with levels above 3.0 mg/L, even when other risk factors like cholesterol are normal.

Metabolic Health Benefits

Lower inflammation levels support better metabolic function, including improved insulin sensitivity and glucose regulation. People with low hsCRP typically have easier weight management, better energy levels, and reduced risk of developing type 2 diabetes.

Enhanced Longevity and Disease Prevention

Chronic inflammation accelerates aging and increases susceptibility to various diseases. Maintaining low hsCRP levels is associated with reduced risk of certain cancers, autoimmune conditions, and neurodegenerative diseases like Alzheimer's. Regular monitoring of your inflammatory markers helps you track your progress toward optimal health and longevity.

Can hsCRP Be Too Low?

While low hsCRP is generally positive, some people wonder if levels can be too low. The short answer is that extremely low hsCRP levels are rarely problematic. Unlike many biomarkers that require balance within a specific range, lower inflammation is almost always better for long-term health.

However, in rare cases, persistently undetectable hsCRP levels might indicate:

  • Certain genetic variations affecting CRP production
  • Extreme malnutrition or protein deficiency
  • Some immunodeficiency conditions
  • Effects of certain medications that suppress inflammation

If you have extremely low hsCRP alongside symptoms like frequent infections, poor wound healing, or unexplained fatigue, discuss these findings with your healthcare provider. For most people, though, low hsCRP simply reflects good health and effective inflammation management.

Factors That Influence hsCRP Levels

Understanding what affects your hsCRP levels empowers you to make targeted improvements. Both modifiable lifestyle factors and non-modifiable characteristics influence this important inflammatory marker.

Lifestyle Factors

Your daily choices significantly impact inflammation levels. Key lifestyle factors include:

  • Diet quality - Processed foods, excess sugar, and trans fats increase inflammation
  • Physical activity - Regular exercise reduces inflammatory markers
  • Sleep quality - Poor sleep elevates hsCRP levels
  • Stress management - Chronic stress triggers inflammatory responses
  • Smoking and alcohol consumption - Both substances promote inflammation
  • Body weight - Excess adipose tissue produces inflammatory compounds

Medical Conditions

Various health conditions can elevate hsCRP levels, including:

  • Autoimmune disorders like rheumatoid arthritis or lupus
  • Chronic infections or inflammatory bowel disease
  • Metabolic syndrome and insulin resistance
  • Sleep apnea and other breathing disorders
  • Periodontal disease and poor oral health

How to Maintain Low hsCRP Levels

Achieving and maintaining low hsCRP levels requires a comprehensive approach to health. The following evidence-based strategies can help reduce inflammation and optimize your hsCRP levels.

Anti-Inflammatory Diet Strategies

Focus on whole, unprocessed foods rich in antioxidants and omega-3 fatty acids. Include plenty of colorful vegetables, fruits, fatty fish, nuts, seeds, and olive oil. Minimize refined sugars, processed meats, and foods high in trans fats. The Mediterranean diet pattern consistently shows benefits for reducing hsCRP levels.

Exercise and Movement

Regular physical activity is one of the most effective ways to reduce inflammation. Aim for at least 150 minutes of moderate-intensity exercise weekly, combining cardiovascular activities with strength training. Even modest increases in daily movement can significantly impact your hsCRP levels.

Stress Reduction and Sleep Optimization

Chronic stress and poor sleep quality directly increase inflammatory markers. Prioritize 7-9 hours of quality sleep nightly and incorporate stress-management techniques like meditation, yoga, or deep breathing exercises. Creating consistent sleep and relaxation routines supports your body's natural anti-inflammatory processes.

When to Test Your hsCRP Levels

Regular hsCRP testing provides valuable insights into your cardiovascular risk and overall health status. Consider testing if you have:

  • Family history of heart disease
  • Other cardiovascular risk factors like high blood pressure or cholesterol
  • Chronic inflammatory conditions
  • Metabolic syndrome or prediabetes
  • Interest in optimizing your health and longevity

For accurate results, avoid testing during acute illness or injury, as these temporarily elevate CRP levels. Wait at least two weeks after recovering from infections or injuries before testing. Consider retesting every 3-6 months when making lifestyle changes to track your progress.

The Bottom Line on Low hsCRP

Low hsCRP levels are indeed a good thing, reflecting minimal inflammation and reduced risk for numerous chronic diseases. While extremely low levels rarely cause concern, the goal for most people should be maintaining hsCRP below 1.0 mg/L through healthy lifestyle choices.

Remember that hsCRP is just one piece of your health puzzle. Combine regular testing with comprehensive health assessments to get the full picture of your cardiovascular and metabolic health. By understanding and optimizing your inflammatory markers, you're taking a proactive step toward better health and longevity.

References

  1. Ridker, P. M. (2016). A Test in Context: High-Sensitivity C-Reactive Protein. Journal of the American College of Cardiology, 67(6), 712-723.[Link][DOI]
  2. Emerging Risk Factors Collaboration. (2010). C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. The Lancet, 375(9709), 132-140.[PubMed][DOI]
  3. Pearson, T. A., et al. (2003). Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107(3), 499-511.[PubMed][DOI]
  4. Kushner, I., Rzewnicki, D., & Samols, D. (2006). What does minor elevation of C-reactive protein signify? The American Journal of Medicine, 119(2), 166.e17-166.e28.[PubMed][DOI]
  5. Kasapis, C., & Thompson, P. D. (2005). The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. Journal of the American College of Cardiology, 45(10), 1563-1569.[PubMed][DOI]
  6. Esposito, K., et al. (2004). Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA, 292(12), 1440-1446.[PubMed][DOI]

Frequently Asked Questions

How can I test my hsCRP at home?

You can test your hsCRP at home with SiPhox Health's Core Health Program, which includes hsCRP testing along with other essential cardiovascular and metabolic biomarkers. This CLIA-certified program provides lab-quality results from the comfort of your home.

What is the optimal hsCRP level for health?

The optimal hsCRP level is below 1.0 mg/L, which indicates low cardiovascular risk and minimal inflammation. Levels between 1.0-3.0 mg/L suggest average risk, while above 3.0 mg/L indicates high risk. Lower is generally better for long-term health.

How quickly can hsCRP levels change?

hsCRP levels can change within days to weeks depending on the cause. Acute infections or injuries can raise levels within 6-8 hours, peaking at 48 hours. Lifestyle changes typically show improvements in hsCRP within 4-8 weeks of consistent healthy habits.

Can medications lower hsCRP levels?

Yes, several medications can lower hsCRP levels, including statins, aspirin, and certain diabetes medications. However, lifestyle modifications often provide similar or better results without side effects. Always consult your healthcare provider before starting any medication.

Should I be concerned if my hsCRP is 0.5 mg/L or lower?

No, hsCRP levels of 0.5 mg/L or lower are excellent and indicate very low inflammation. Unlike many biomarkers, there's no lower limit of concern for hsCRP in healthy individuals. These low levels suggest good cardiovascular health and effective inflammation management.

Related Articles

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details